Newman Dignan & Sheerar, Inc. Oncolytics Biotech Inc Transaction History
Newman Dignan & Sheerar, Inc.
- $585 Million
- Q3 2024
A detailed history of Newman Dignan & Sheerar, Inc. transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 22,015 shares of ONCY stock, worth $18,712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,015Holding current value
$18,712% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding ONCY
# of Institutions
44Shares Held
1.21MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL200KShares$170,3400.02% of portfolio
-
Seeds Investor LLC New York, NY190KShares$161,4490.06% of portfolio
-
Goldman Sachs Group Inc New York, NY85KShares$72,2480.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il79.2KShares$67,3610.0% of portfolio
-
Royal Bank Of Canada Toronto, A674.5KShares$63,3640.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $49.2M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...